KR100250847B1 - 산화방지 특성을 지닌 합성 폐 표면활성제 - Google Patents

산화방지 특성을 지닌 합성 폐 표면활성제 Download PDF

Info

Publication number
KR100250847B1
KR100250847B1 KR1019940701486A KR19940701486A KR100250847B1 KR 100250847 B1 KR100250847 B1 KR 100250847B1 KR 1019940701486 A KR1019940701486 A KR 1019940701486A KR 19940701486 A KR19940701486 A KR 19940701486A KR 100250847 B1 KR100250847 B1 KR 100250847B1
Authority
KR
South Korea
Prior art keywords
amino acid
leu
lys
group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940701486A
Other languages
English (en)
Korean (ko)
Inventor
알. 맥린 래리
에이치. 페인 마거리트
Original Assignee
슈테펜 엘. 네스비트
메렐 다우 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 슈테펜 엘. 네스비트, 메렐 다우 파마슈티칼스 인크. filed Critical 슈테펜 엘. 네스비트
Application granted granted Critical
Publication of KR100250847B1 publication Critical patent/KR100250847B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
KR1019940701486A 1991-11-04 1992-10-13 산화방지 특성을 지닌 합성 폐 표면활성제 Expired - Fee Related KR100250847B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7/789.918 1991-11-04
US07/789,918 US5272252A (en) 1991-11-04 1991-11-04 Synthetic lung surfactant having antioxidant properties
PCT/US1992/008728 WO1993008824A1 (en) 1991-11-04 1992-10-13 Synthetic lung surfactant having antioxidant properties

Publications (1)

Publication Number Publication Date
KR100250847B1 true KR100250847B1 (ko) 2000-09-01

Family

ID=25149105

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940701486A Expired - Fee Related KR100250847B1 (ko) 1991-11-04 1992-10-13 산화방지 특성을 지닌 합성 폐 표면활성제

Country Status (15)

Country Link
US (2) US5272252A (enExample)
EP (1) EP0666754B1 (enExample)
JP (1) JPH07502500A (enExample)
KR (1) KR100250847B1 (enExample)
AT (1) ATE175116T1 (enExample)
AU (1) AU667200B2 (enExample)
CA (1) CA2121147C (enExample)
DE (1) DE69228077T2 (enExample)
DK (1) DK0666754T3 (enExample)
ES (1) ES2127764T3 (enExample)
FI (1) FI942032A7 (enExample)
GR (1) GR3029279T3 (enExample)
HU (1) HUT66424A (enExample)
NO (1) NO941616D0 (enExample)
WO (1) WO1993008824A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36460E (en) * 1990-10-10 1999-12-21 Life Science Holdings, Inc. Method of providing circulation via lung expansion and deflation
US5653685A (en) * 1990-10-10 1997-08-05 Lrt, Inc. Method of providing circulation via lung expansion and deflation
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
ES2107048T3 (es) * 1992-07-31 1997-11-16 Merrell Pharma Inc Tensioactivos pulmonares peptidicos sinteticos con antioxidantes covalentemente unidos.
EP0886652B1 (en) * 1995-11-20 2002-04-17 Ortho-McNeil Pharmaceutical, Inc. Pulmonary surfactant peptide solubilization process
WO1997032621A1 (en) * 1996-03-08 1997-09-12 Life Resuscitation Technologies, Inc. Liquid ventilation method and apparatus
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties
GB2368339B (en) * 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
AU2003223718B2 (en) * 2002-04-25 2007-08-16 The Scripps Research Institute Treatment and prevention of pulmonary conditions
US7290197B2 (en) * 2003-06-03 2007-10-30 Quantum Corporation Correcting data using redundancy blocks
US20060121016A1 (en) * 2004-10-18 2006-06-08 Lee Raphael C Methods and compositions for treatment of free radical injury
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
ES2380046T3 (es) 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar
WO2007001094A1 (ja) * 2005-06-29 2007-01-04 Sannamu Lee 人工肺サーファクタント組成物
MX2009003002A (es) * 2006-09-19 2009-06-01 Discovery Lab Inc Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
KR102221365B1 (ko) * 2019-05-07 2021-03-02 (주)케어젠 트롤록스-펩타이드 결합체 및 그의 용도
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US4912038A (en) * 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4705684A (en) * 1985-05-31 1987-11-10 The University Of Tennessee Research Corporation Synthetic M proteins - streptococci type 6
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
US4918161A (en) * 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
US5055553A (en) * 1985-09-26 1991-10-08 Genetics Institute Inc. Low molecular weight pulmonary surfactant proteins
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス ノバ インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量6,000ダルトンのタンパク質及びその多量体
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト,ジエフリー エイ. 肺胞疎水性界面活性物質関連タンパク質
WO1989000167A1 (en) * 1987-07-01 1989-01-12 Kabigen Ab Proteins and protein compositions and their use
WO1989004326A1 (en) * 1987-11-04 1989-05-18 California Biotechnology Inc. Alveolar surfactant proteins
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
AR245141A1 (es) * 1988-07-01 1993-12-30 Merrell Dow Pharma Procedimiento de sintesis secuencial o de bloques en fase solida para preparar polipeptidos de estructura helicoidal.
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5134129A (en) * 1989-03-15 1992-07-28 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
WO1990011768A2 (en) * 1989-03-31 1990-10-18 Genentech, Inc. Method for treating respiratory distress syndrome
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties

Also Published As

Publication number Publication date
ES2127764T3 (es) 1999-05-01
EP0666754B1 (en) 1998-12-30
EP0666754A1 (en) 1995-08-16
FI942032L (fi) 1994-05-03
FI942032A0 (fi) 1994-05-03
JPH07502500A (ja) 1995-03-16
AU667200B2 (en) 1996-03-14
DE69228077D1 (de) 1999-02-11
DK0666754T3 (da) 1999-08-30
GR3029279T3 (en) 1999-05-28
EP0666754A4 (en) 1996-06-26
FI942032A7 (fi) 1994-05-03
HU9401293D0 (en) 1994-08-29
CA2121147C (en) 2002-12-10
US5683982A (en) 1997-11-04
CA2121147A1 (en) 1993-05-13
NO941616D0 (no) 1994-05-03
WO1993008824A1 (en) 1993-05-13
ATE175116T1 (de) 1999-01-15
AU2778392A (en) 1993-06-07
NO941616L (enExample) 1994-06-24
HUT66424A (en) 1994-11-28
US5272252A (en) 1993-12-21
DE69228077T2 (de) 1999-07-08

Similar Documents

Publication Publication Date Title
KR100250847B1 (ko) 산화방지 특성을 지닌 합성 폐 표면활성제
EP0652894B1 (en) Synthetic peptide lung surfactants having covalently bonded antioxidants
AU2008286026B2 (en) Synthetic pulmonary surfactant peptides
US6613734B2 (en) Peptides-containing liposomal surfactants
EP0348967A2 (en) Synthetic lung surfactant preparation comprising lipids and polypeptides
KR100279540B1 (ko) 펩티드 폐 계면활성제 및 치료용 혼합물
CA2137349C (en) Peptide lung surfactants and therapeutic combinations
HK1144435A (en) Synthetic pulmonary surfactant peptides

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20031229

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20050108

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20050108